PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA

Discussing Rheumatology: November 2023

Bimekizumab in treating bDMARD-naïve PsA & upadacitinib in treating csDMARD and bDMARD IR PsA

AxSpA Podcast: Safety and Efficacy of Upadacitinib

CSF Author Interview: Dr. David Martin, 2023

Discussing Rheumatology: October 2023

EULAR Recommendations Podcast 2023 with Professor Peter Nash & Dr. Andreas Kerschbaumer

Author Interview: Professor Martin Bergman, 2023

Upadacitinib treating bDMARD-IR PsA & Post-marketing surveillance of tofacitinib treating PsA & RA

AxSpA Podcast: The Efficacy and Safety of Ixekizumab & Tildrakizumab

Discussing Rheumatology: September 2023

Author Interview: Sofia Ramiro

Discussing Rheumatology: August 2023

AxSpA Podcast: Tofacitinib, Golimumab, and Fatigue

Discussing Rheumatology: July 2023

PsA Podcast: Secukinumab in Oligoarticular PsA & JAK Inhibition-related Malignancies

Author Interview: Laura Coates

Author Interview: Mark Russell

Discussing Rheumatology: June 2023

AxSpA Podcast: Secukinumab Optimisation & Ixekizumab Treatment for PAEs

Discussing Rheumatology: May 2023

Author Interview: Shikha Singla

AxSpA Podcast: AS Associated MACE & Upadacitinib's Long Term Safety

Discussing Rheumatology: April 2023

PsA Podcast: Herpes Zoster in JAK Inhibitor Therapies & The APEX Protocol

Discussing Rheumatology: March 2023

Discussing Rheumatology: February 2023

Discussing AxSpA: Episode 5

Discussing Rheumatology: January 2023

Author Interview: Kevin Winthrop

Discussing PsA: Episode 5

Author Interview: Rebecca Haberman